End Taxpayer Subsidies for Drug Ads Act

Summary

End Taxpayer Subsidies for Drug Ads Act This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 1 March 2018

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 1 March 2018

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 1 March 2018 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 1 March 2018

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 1 March 2018

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 1 March 2018

  Open at official source

Sponsors

• Sen. McCaskill, Claire [D-MO] · D · Sponsor
• Jeanne Shaheen · D · Sponsor
• Sen. Brown, Sherrod [D-OH] · D · Cosponsor
• Angus King · I · Cosponsor
• · ssfi00 · Standing

Related records

• related to → Improving Access To Affordable Prescription Drugs Act
• related to → Improving Access To Affordable Prescription Drugs Act
• related to ← Affordable Medications Act